title: Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.
authors.forename: A J
authors.initials: AJ
authors.lastname: Krentz
authors.forename: J
authors.initials: J
authors.lastname: Dmitrewski
authors.forename: D
authors.initials: D
authors.lastname: Mayer
authors.forename: P
authors.initials: P
authors.lastname: McMaster
authors.forename: J
authors.initials: J
authors.lastname: Buckels
authors.forename: J M
authors.initials: JM
authors.lastname: Smith
authors.forename: M
authors.initials: M
authors.lastname: Nattrass
mesh_terms: D016572:Cyclosporine / Q000009:adverse effects*; D018149:Glucose Intolerance / Q000139:chemically induced*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D016031:Liver Transplantation; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus